ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ТЕХНОЛОГИИ КАРДИОЛОГ"
SENSE2BEAT at Glance.
SENSE2BEAT is a seed stage direct-to-consumer digital health startup commercializing an effective and affordable cardiac arrhythmias detection. SENSE2BEAT revolutionary approach is enabled by a platform-independent A.I.–based Clinical Decision-Support System.
We work to enhance a quality of ECG-based R-R interval measurement arrhythmia detection taking advantage of emerging innovative technologies in medical monitoring wearables and A.I research. We value flexibility, evidence-based approach and consumer simplicity.
Cloud-based SENSE2BEATTM A.I. will constantly evolve through artificial intelligence with a dedicated team feeding it new annotated and raw databases, and physicians validating its analysis, intervention and prediction. SENSE2BEATTM will airdrop updated client A.I. modules via subscription-based SAAS service worldwide and offer real-time connectivity and response upon arrhythmic event detection. With our evolutionary algorithms tailored for prolonged monitoring devices, we will aim to increase arrhythmia detection rate compared to standard methods.
We intend to create the new and potentially disruptive market of direct-to-consumer arrhythmia detection A.I., projected as a $4.2B market. This underserved segment of addressing first arrhythmic events before they become chronic conditions is where SENSE2BEATTM can make a significant impact.
Упоминание в СМИ
Информация о компании
ПОДЛАДЧИКОВА ТАТЬЯНА ВЛАДИМИРОВНА
СТЕПАНОВА ДАРЬЯ КИРИЛЛОВНА
ГЛАЗКОВА НАТАЛЬЯ ЮРЬЕВНА